Drugs and Treatments
Analyzing GLP-1 Drugs: Innovations in Metabolism and Treatment
This article explores advancements in GLP-1 medications for obesity treatment, including implications for cognitive health and addiction therapy.
Medicine
Infections
Uganda Sees 34,000 New HIV Cases in 2025, Young Women Most Affected
In 2025, Uganda reported 34,000 new HIV infections, with young women particularly impacted, making urgent interventions critical.
Vaccines
GSK Sees 30% Profit Growth Driven by Medicines and Vaccines
GlaxoSmithKline's Q2 report shows a 30% increase in profit, fueled by strong vaccine and medicine sales.
Vaccines
GPN Vaccines Secures $10 Million for Pneumococcal Vaccine Progress
GPN Vaccines has raised $10 million to advance its Gamma-PN pneumococcal vaccine into Phase 2 trials, broadening its impact against a serious health threat.
Infections
Revolutionary Virus Therapy Offers Hope Against Superbug Infections
Phage therapy emerges as a promising alternative for patients battling antibiotic-resistant infections.
Drugs and Treatments
New Clinical Trial Aims to Expedite Alzheimer's Treatment Research
A UK-based trial is testing diabetes and ADHD medications for their potential benefits in Alzheimer's care.
Medicine
Integrating Lifestyle Medicine into Electronic Health Records
The American College of Lifestyle Medicine partners with eClinicalWorks to enhance patient care through electronic health records.
Vaccines
GPN Vaccines Secures $10 Million to Advance Revolutionary Pneumococcal Vaccine
GPN Vaccines has successfully closed a $10 million financing round to further develop Gamma-PN™, a novel serotype-independent pneumonia vaccine.
Vaccines
Impact of Maternal RSV Vaccine: Significant Reduction in Hospitalizations
Recent findings reveal maternal vaccination against RSV is leading to fewer hospitalizations for infants.
Medicine
Key Highlights from the World Conference on Traditional Medicine 2026
The World Conference on Traditional Medicine 2026 in Beijing concluded with significant outcomes aimed at enhancing global health practices.
Drugs and Treatments
Eli Lilly's Revenue Soars 39% Driven by Obesity Medications
Eli Lilly boosts revenue forecast to $91-$92 billion, fueled by demand for its obesity drugs Mounjaro and Zepbound.
Medicine
Global Milestones Mark the 2026 Traditional Medicine Conference
The World Conference on Traditional Medicine 2026 concluded in Beijing with significant achievements aimed at enhancing global health cooperation.